Every record from Janoshik · page 24
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042053 | Tirzepatide | TFC | TFC-2508-L6746 | 2026-Q1 | 98.37 | 2.18 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041492 | TB-500 | QYB | QYB-2512-R5934 | 2026-Q1 | 99.93 | 4.27 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041423 | GHRP-2 | WWB | WWB-2511-K4194 | 2026-Q1 | 99.73 | 4.87 | 98.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042716 | Retatrutide | GGPeps | GGPE-2511-W9618 | 2026-Q1 | 97.62 | 6.19 | 95.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042382 | Tirzepatide | SWB | SWB-2601-V4383 | 2026-Q1 | 99.25 | 4.12 | 94.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043357 | BPC-157 | CPC | CPC-2510-R2456 | 2026-Q1 | 97.85 | 8.78 | 107.1 | Buyer-sourced | 1 | FAIL |
| AX-2026-042766 | Ipamorelin | GGPeps | GGPE-2508-E9990 | 2026-Q1 | 99.93 | 5.26 | 104.7 | Supplier-supplied | 0 | PASS |
| AX-2026-042704 | Melanotan II | GGPeps | GGPE-2509-H8939 | 2026-Q1 | 98.60 | 5.51 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041909 | TB-500 | JEEP | JEEP-2510-R4058 | 2026-Q1 | 99.62 | 4.86 | 96.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041783 | TB-500 | FGP | FGP-2601-T1617 | 2026-Q1 | 99.44 | 4.27 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041345 | CJC-1295 with DAC | WWB | WWB-2508-V3100 | 2026-Q1 | 99.50 | 6.14 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043466 | IGF-1 LR3 | WXT | WXT-2508-T5737 | 2026-Q1 | 97.74 | 3.61 | 97.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043413 | Tesamorelin | WXT | WXT-2601-A4454 | 2026-Q1 | 96.61 | 4.25 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-043064 | Epitalon | KP | KP-2508-Y5329 | 2026-Q1 | 98.06 | 8.31 | 100.4 | Laboratory-retained | 0 | FAIL |
| AX-2026-043055 | Semax | KP | KP-2509-J5482 | 2026-Q1 | 99.79 | 9.71 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042452 | MGF | SWB | SWB-2601-E6319 | 2026-Q1 | 99.03 | 4.64 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041236 | Retatrutide | WWB | WWB-2510-H1662 | 2026-Q1 | 99.25 | 4.73 | 90.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043492 | Leuprolide | WXT | WXT-2511-S5991 | 2026-Q1 | 98.35 | 6.16 | 97.1 | Supplier-supplied | 0 | FAIL |
| AX-2026-043474 | BPC-157 | WXT | WXT-2508-E5954 | 2026-Q1 | 97.58 | 3.65 | 98.0 | Supplier-supplied | 2 | FAIL |
| AX-2026-042241 | Melanotan II | Homopeptide | HOMO-2511-M1199 | 2026-Q1 | 99.64 | 3.64 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041822 | Retatrutide | FGP | FGP-2512-V2097 | 2026-Q1 | 98.70 | 5.61 | 98.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041675 | Ipamorelin | QSC | QSC-2602-W8804 | 2026-Q1 | 99.38 | 5.75 | 90.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041639 | Selank | QSC | QSC-2601-N8430 | 2026-Q1 | 99.81 | 6.37 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041544 | 5-Amino-1MQ | QYB | QYB-2510-C6129 | 2026-Q1 | 99.13 | 3.53 | 105.6 | Supplier-supplied | 1 | FAIL |
| AX-2026-043484 | BPC-157 | WXT | WXT-2602-P5658 | 2026-Q1 | 98.24 | 2.30 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2026-041759 | Selank | FGP | FGP-2511-D1094 | 2026-Q1 | 99.93 | 6.40 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041237 | Retatrutide | WWB | WWB-2510-H1662 | 2026-Q1 | 98.82 | 5.21 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042493 | Melanotan II | SWB | SWB-2602-J6019 | 2026-Q1 | 99.93 | 4.15 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042486 | Melanotan II | SWB | SWB-2602-J6019 | 2026-Q1 | 99.58 | 4.26 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041908 | TB-500 | JEEP | JEEP-2510-R4058 | 2026-Q1 | 99.93 | 5.24 | 97.4 | Supplier-supplied | 0 | PASS |
| AX-2026-041587 | Semaglutide | QSC | QSC-2509-Y7423 | 2026-Q1 | 99.71 | 5.45 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041321 | ARA-290 | WWB | WWB-2511-S3009 | 2026-Q1 | 99.93 | 4.64 | 93.0 | Supplier-supplied | 0 | PASS |
| AX-2026-043230 | N-Acetyl Semax Amide | SGN | SGN-2508-K1228 | 2026-Q1 | 99.93 | 7.33 | 93.8 | Supplier-supplied | 0 | PASS |
| AX-2026-042613 | Semax | GGPeps | GGPE-2511-X8435 | 2026-Q1 | 98.00 | 7.31 | 90.3 | Supplier-supplied | 1 | FAIL |
| AX-2026-042356 | TB-500 | HJ | HJ-2601-H3602 | 2026-Q1 | 99.26 | 6.42 | 102.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042310 | Tirzepatide | HJ | HJ-2508-P3416 | 2026-Q1 | 98.80 | 4.50 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2026-041645 | Selank | QSC | QSC-2601-N8430 | 2026-Q1 | 99.93 | 6.62 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041358 | Semaglutide | WWB | WWB-2508-S3298 | 2026-Q1 | 99.41 | 5.01 | 103.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041641 | Selank | QSC | QSC-2601-N8430 | 2026-Q1 | 99.93 | 6.31 | 99.5 | Supplier-supplied | 0 | PASS |
| AX-2026-042734 | Tirzepatide | GGPeps | GGPE-2510-L9923 | 2026-Q1 | 97.59 | 4.37 | — | Buyer-sourced | 2 | MARGINAL |